| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vaxcyte, Inc. (PCVX) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 20 sells. PCVX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 496.9K | $25.90M | - | |
| COO | 160.7K | $8.38M | - | |
| CFO | 104.4K | $5.44M | - | |
| Other | 76.0K | $3.96M | - | |
| VP | 29.0K | $1.51M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 19, 2022 | Wassil Jim53 | Chief Operating Officer | Sale+OE | 2,800 | $26.11 | $73,111.08 | -3.2% | +64.8% | +93.0% | |
| Sep 15, 2022 | Pickering Grant50 | Chief Executive Officer | Sell | 11,000 | $27.95 | $307,412.60 | -1.7% | +62.0% | +83.3% | |
| Sep 6, 2022 | Fairman Jeff | VP, Research | Sell | 5,000 | $26.58 | $132,892.13 | -0.8% | +71.4% | +96.4% | |
| Aug 29, 2022 | Guggenhime Andrew46 | President And CFO | Sale+OE | 36,000 | $28.00 | $1,008,000.00 | -22.1% | +57.8% | +85.7% | |
| Aug 26, 2022 | Pickering Grant50 | Chief Executive Officer | Sell | 10,000 | $27.44 | $274,416.24 | -1.5% | +58.3% | +80.9% | |
| Aug 22, 2022 | Sauer Paul | SVP Process Dev, Manufacturing | Sell | 3,000 | $25.93 | $77,784.90 | -17.0% | +71.4% | +89.7% | |
| Aug 18, 2022 | Guggenhime Andrew46 | President And CFO | Sale+OE | 3,100 | $25.26 | $78,320.24 | -3.5% | +65.7% | +90.4% | |
| Aug 17, 2022 | Wassil Jim53 | Chief Operating Officer | Sale+OE | 2,800 | $25.15 | $70,407.12 | -5.9% | +75.9% | +89.4% | |
| Aug 15, 2022 | Pickering Grant50 | Chief Executive Officer | Sell | 11,000 | $25.58 | $281,402.08 | -0.8% | +69.1% | +82.4% | |
| Aug 5, 2022 | Fairman Jeff | VP, Research | Sell | 15,000 | $25.57 | $383,507.50 | -2.4% | +72.8% | +91.5% |